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A. Preliminary
The issue of protecting traditional knowledge is
a very complex issue 1Where these issues arise with
the development of the pharmaceutical industry.
Pharmacy is the application of various sciences such
as health, chemistry, physics, and biology, work in the
field of pharmacy can be said to be complex, starting
from research, manufacturing, compounding,
provision of drug preparations, testing, and drug
information services or related services to patients.
Moreover, with the era of the industrial revolution 4.0
from and in several aspects. First, innovations and
ideas can be disseminated and developed faster than
ever before which is still relatively slow. Second, a
significant reduction in production costs and the
emergence of a platform that collaborates several
concentration activities in several sectors and
increases the yield income. Third,2
Pharmaceutical Industry 4.0. This is a new way
in which to manage the pharmaceutical industry,
combining the online as offline environment. This
concept can be applied to pharmaceutical
manufacturing problems to significantly increase
productivity and quality, reduce risk and waste. In
addition to improving real-time monitoring and
traceability from the supply chain to the end
consumer. Also, it seeks to automate complex
management and documentation processes, to make
more efficient adaptations to regulatory requirements.3
Traditional knowledge relates to three
categories, namely traditional knowledge in meaning
(technical knowledge, practices, skills, and
innovations related to, biodiversity, agriculture or
health); traditional cultural expressions / folklore
expressions (cultural manifestations such as music,
art, designs, symbols and performances); and genetic
resources (genetic material of actual or potential value
found in plants, animals and microorganisms).
Traditional knowledge includes knowledge, skills,
innovation, practice, teaching and learning that are
developed in indigenous or local communities and
which are passed down from generation to
generation.4
The geographical condition of Indonesia which
consists of islands and tribes has made the diversity of
people's traditional knowledge diverse. The
characteristics of traditional knowledge in various
regions are based on human resources, natural
resources, environment, and infrastructure.The people
of Java, Banten Kidul in Banten, the Community of
Kota Banjar Baru in South Kalimantan, the Papuan
Community in Papua, the Benuaq Dayak Community,
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West Kutai, East Kalimantan, the East Kalimantan
Dayak Community, and the Tiloko Community in
Southeast Sulawesi are among Indonesians who have
used various plants as medicine. For example, the
Javanese use the samiloto plant in a mixture of herbs.5
This article will examine the existence of traditional
knowledge of Indonesian society in the field of
medicine in the development of pharmaceutical
industry technology.
B. Discussion
1. Traditional Knowledge in International
Instruments World International Property
Organization
WIPO classifies traditional knowledge into
agricultural knowledge, scientific knowledge,
ecological knowledge, medicinal knowledge including
related medicine and medicine, knowledge related to
biodiversity, folklore in the fields of music, dance,
song, handicraft, language elements, and objects.
moving cultural objects.
In the international discourse it is agreed that
the term traditional knowledge is divided into three
types: Traditional Medical Knowledge, Traditional
Agricultural Knowledge and Traditional Ecological
Knowledge.6 Traditional knowledge is part of the
category of traditional knowledge that is owned and
used by the community of origin.Traditional
knowledge includes agricultural knowledge, scientific
knowledge, technical knowledge, ecological
knowledge, medicinal knowledge, biodiversity
knowledge, folklore expressions in the form of music,
dance, songs, crafts, form engineering, stories, and
works of art, language elements, such as names,
geographical indications and symbols, and the nature
of mobile culture.7
2. Intergovernmental Committee on Intellectual
Property and Genetic Resources, Traditional
Knowledge and Folklore (IGC GRTKF)
IGC GRTKF is a committee initiated by WIPO
in order to discuss issues of access to genetic
resources, traditional knowledge and traditional
cultural expressions. This committee was founded in
2000 and in the first IGC GRTKF meeting in 2001,
began discussing the draft goals and principles
proposed by Australia, Canada, New Zealand, Norwey
and America in the context of protection of genetic
resources through sui generis because there is a clear
link. between genetic sources and IPR under TRIPs.8
Meetingfourth, one of the discussions is the
need to mention the source of origin related to genetic
resources and traditional knowledge. The IGC
GRTKF also accompanied the invitation to the COP-6
CBD, to give views regarding the mention of the
source of the origin of genetic resources. IGC GRTKF
has responded to the CBD invitation by affirming the
mention of the source of origin in the patent
application for the protection of genetic resources and
traditional knowledge.9
During the IGC GRTKF discussions, WIPO
members committed to implementing the mention of
the source of origin in the IPR system. however, the
GRTKF IGC in 2010, has reserved guidelines for
patent application procedures with the mention of
source of origin. The GRTKF IGC has also defined
the term 'traditional knowledge'. In general, traditional
knowledge consists of skills, innovations, and
practices that are rooted in indigenous communities
and are usually passed down orally from generation to
generation. It is related to the traditional culture of
indigenous peoples and is used by the community in
their daily life. Traditional knowledge of indigenous
peoples includes knowledge of healing properties,
farming methods, migration of wild animals and birds
and traditional hunting and fishing techniques.10
Committee in meeting at Geneva, on 17-21
June 2019has committed to protecting traditional
knowledge, which emphasizes that the protection of
traditional knowledge must contribute to the
promotion of creativity and innovation and for the
transfer and dissemination of knowledge must
mutually benefit the holders and users in a balanced
manner of rights and obligations. This has been
emphasized in the draft April 2019 article in Geneva
that recognizes and reaffirms the role of the IPR
system in promoting innovation and creativity,
transfer and dissemination of knowledge from
stakeholders, providers and users of traditional
knowledge.11 So IGC GRTKF is committed to
protecting traditional knowledge through the IPR
system.
3. Convention on Biological Diversity (CBD)
Convention on Biological Diversity (CBD) is
the approval of thecountries at a conference on
Environment and Development in Rio de Jeneiro
Brazil, in 1992. At the conference, the issue of First,
the objective is to ensure the sharing of benefits from
the use of biodiversity. And second, the goal of
allowing indigenous peoples or legal owners to share
benefits from the commercial use of biodiversity.12
The two issues are the obligations that need to be
implemented in terms of access to biodiversity.
This has been affirmed in article 8 (j) CBD
that: Each Contracting Party shall, as far as possible
and as appropriate: Subject to its national legislation,
respect, preserve and maintain knowledge,
innovations and practices of indigenous and local
communities embodying traditional lifestyles for the
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conservation and sustainable use of relevant biological
diversity and promote their wider application with the
approval and involvement of the holders of such
knowledge, innovations and practices and encourage
the equitable sharing of the benefits arising from the
utilization of such knowledge, innovations and
practices.
Article 8 (j) of the CBD provides a reference to
the traditional knowledge of society which must be
respected, protected and defended. Traditional
knowledge is knowledge of indigenous and local
people from generation to generation in the use of
biodiversity which includes information about various
types of plants processed for medicine (KR Srinivas;
2008).13 So, traditional knowledge that reflects the
traditional styles and characteristics of the original and
local people in meeting the needs of life, including
medicine.
Indonesia has ratified the CBD through Law
No. 5/1994. This ratification has strengthened
Indonesia to realize the mandate of article 8.j in
national legislation. This is because the use of
traditional knowledge in the pharmaceutical industry
is increasing and the more sophisticated
pharmaceutical technology in the 4.0 era.
4. In IPR legislation in Indonesia Plant Variety
Protection Act
In Law Number 29 of 2000 concerning
Protection of Indonesian Plant Varieties (PVP Law)
does not protect traditional varieties that have been
cultivated by farmers, which is the knowledge of the
community in the agricultural sector. This is because
plant cultivation does not use biotechnology and only
uses traditional agricultural knowledge that has been
passed down from generation to generation. Article 1
paragraph (4) states, plant breeding is a series of
research and testing activities or variety discovery and
development activities, in accordance with standard
methods for producing new varieties and maintaining
the purity of seeds of the varieties produced.
Furthermore, Article 2 has reaffirmed that plant
varieties that are given protection must meet new,
unique, uniform, stable varieties and be given names.
Therefore,
However, Article 7 states that the state controls
local varieties owned by the community. These local
varieties refer to existing varieties that have been
cultivated by farmers from generation to generation
and are based on traditional agricultural knowledge
and belong to the community. In Government
Regulation No.13 / 2004, it is reaffirmed that to
control local varieties, it is given to the Regent or
Mayor to act for and on behalf of the people in his
area as owners of local varieties. This must be done in
order to strengthen the need for protecting the
traditional knowledge of the community in
agriculture.
5. In the Patent Law in Indonesia
Law No.13 / 2016 concerning Patents has
emphasized that inventions relating to and / or
originating from genetic resources and / or traditional
knowledge, must clearly and correctly state the origin
of the genetic resources and / or traditional knowledge
in the description. Information on genetic resources
and / or traditional knowledge as intended is stipulated
by an official institution recognized by the
government. The sharing of yields and / or access to
the use of genetic resources and / or traditional
knowledge is carried out in accordance with laws and
regulations and international agreements in the field of
genetic resources and traditional knowledge (Article
26 paragraph (1), (2), (3) of the Patent Law. ).
This provision in the Patent Law is one way to
protect the use of traditional public knowledge in
pharmaceutical products in the era of technology 4.0.
Where, the pharmaceutical industry which registers its
products must clearly state the information as the
source of origin of the product. Considering on the
other hand, the traditional knowledge of the people
obtained is directly registered in the IPR system
because there is no element of novelty as required in
patent registration. Thus the protection of traditional
knowledge in the IPR system becomes constrained.
6. The need to protect traditional knowledge
There are two purposes for the protection of
traditional knowledge, namely as bio-economics
and moral rights. As a bio-economy, the use of
traditional knowledge. In the midst of
technological developments, the pharmaceutical
industry is intensively using traditional knowledge
in the health sector.14 The pharmaceutical industry
contributes 50 percent of herbal-based medicines
in the world.15Sales of vinblastine as a medicine
for Hodgkindan disease and Vincristine as a
leukemia drug were found in the Tapak Dara
specimens found in Madagascar. This activity
generates more than US $ 200 million a year for
Eli Lilly Corporation as a pharmaceutical producer
from America.16 Sales of herbal medicinal
products in Europe reached US $ 1.6 billion to US
$ 3.3 billion in 1998, while in America it reached
US $ 6 billion in 1988. The use of traditional
medicines in developing countries such as India
reached 65 percent of the population of India,
when in Africa it is up to 80 percent of the
population of Africa.17 Therefore it is important,
economically, to protect the use of traditional
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knowledge of the community, including in the
field of medicine for the welfare of society.
As a moral right, in the teachings of Natural
Law, Socrates emphasized that moral power is the
essence of law, because without morality, laws will
lose their supremacy and independence. Therefore,
fair and unfair will be measured through the value of
morality.18 Thomas Aquinas also emphasized morality
is a human being possessed because reason given by
God is for do the good and avoid the bad.19 When,
Grotius and Immanuel Kant is a proponent of the
Rational Law of Nature which affirms that moral is
based on the reasoning of human reason or mind,
which can shows what is true and what is not. Agood
reasons and actions therein have a moral quality,20
including the act of using the community's traditional
knowledge in a responsible manner as a gift from
God, as a truth and action that is useful and brings
happiness to society.21Therefore, in the development
of pharmaceutical technology in the era of 4.0. The
need for protection of traditional knowledge is getting
higher considering that the higher the human intellect,
the higher the level of morality for the use of
traditional knowledge in society.
C. Conclusion
The protection of traditional knowledge amidst
the development of pharmaceutical industry
technology in the era of 4.0, really requires a
harmonization of the regulatory system with the
implementation and control of the government and
community groups. Where, at the international level, it
has paid respect to community rights, including
traditional knowledge. In IPR legislation, it has also
emphasized the obligation to mention the source of
origin of the product to be patented. In addition, there
is also a need for specific regulations governing
traditional knowledge considering that this has very
different characteristics from the innovative products
in the IPR system.
References
1 Martens, P. and T. Soobramanien (2016),
"Fostering Development of Local Communities
Through the Protection of Traditional Knowledge
and Origin Products", International Trade Working
Paper, No. 2016/12, Commonwealth Secretariat,
London,https://doi.org/10.14217/5jm26c5slbjh-en
; Vikram S. Negi, Ravi Pathak, K. Chandra Sekar,
RS Rawal, ID Bhatt, SK
Nandi & PP Dhyani, Traditional knowledge and
biodiversity conservation: a case study from Byans
Valley in Kailash Sacred Landscape, India, Journal
of Environmental Planning and Management, 2017
2 Alani MM, Alloghani M. (2019) Security
Challenges in the Industry 4.0 Era. In: Dastbaz
M., Cochrane P. (eds) Industry 4.0 and
Engineering for a Sustainable Future. Springer,
Cham
3 Zezulka, F., Marcon, P., Vesely, I., & Sajdl, O.
(2016). Industry 4.0 – an introduction in the
phenomenon. IFAC-PapersOnLine, 49 (25), 8–12.
4 Bandyopadhyay D. (2018) Protection of
Traditional Knowledge and Indigenous
Knowledge. In: Securing Our Natural Wealth.
South Asia Economic and Policy Studies.
Springer,Singapore, Securing Our Natural
Wealth, 59-70
5 Sa'roni, et al, 'Profile of traditional medicinal herbs
and medicinal herbs used in Southeast Sulawesi,
South Kalimantan and Lampung provinces', (2011)
21 (2), Media Research and Development for
Health, 71-8; Elfahmi et al, Jamu: Indonesian
traditional herbal medicine towards rational
phytopharmacological use, (2014) Journal of
Herbal Medicine 1-52.
6 T. Cottier, M. Panizzon, Legal perspectives on
traditional knowledge, (2004) (2), Journal of
International Economic Law, 371–399
7 WIPO, 2010.
8 G. Dutfield & U. Suthersanen, Global Intellectual
Property Law, Edward Elgar Publishing, UK, 2008
9 WIPO; 2004-2008.
10 Wendland, Wend. International negotiations at
WIPO on intellectual property and genetic
resources, traditional knowledge and traditional
cultural expressions: Analysis of the process so far
and thoughts on possible future directions, journal
of the Intellectual and Industrial Property Society
of Australia and New Zealand, No. 114, Dec 2018:
31-38
11 WIPO; 2019
12 M. Lewis, 2010-2011, Bioprospecting in the Wake
of CBD COP10: The Adoption of the Nagoya
Protocol, (2011) 19 (2), ILSA Quart, 18-25
13 CBD does not use the term indigenous peoples, but
uses the term indigenous communities which
reflects a traditional lifestyle (indigenous and local
communities embodying traditional lifestyle). In
terms of indiginous knowledge and traditional
knowledge, there are differences. Basically,
indigenous knowledge is the term used to identify
knowledge possessed by indigenous people.
Although indigenous knowledge is generally
considered traditional knowledge¸ but not all
traditional knowledge is indigenous knowledge.
Yulia : Protection of Traditional Knowledge of Indonesian Society 225
Because indigenous knowledge is similar to
traditional knowledge, both in terms of
distribution, scope and types.
14 T. Kate, S. Laird, The Commercial Use of
Biodiversity: Access to Genetic Resources and
Benefit-Sharing, Commission of the European
Communities and Earthscan Publications Ltd,
London, 1999
15 T. Kate, S. Laird, The Commercial Use of
Biodiversity: Access to Genetic Resources and
Benefit-Sharing, p. 35; C. Richerzhagen, et al, 'The
effectiveness of access and benefit sharing in
Costa Rica: implications for national and
international regimes', (2005) 53, Ecological
Economic, 445-460
16 AW Torrance, 'Patent law, Hippo and biodiversity
crisis', (2010) 9, Journal Mashall Review
Intellectual Property Law, 624-656.
17 K. Timmermans, 'Intellectual property rights and
traditional medicine: policy dilemmas at the
interface', (2003), 57, Social Science & Medicine,
745–756.
18 Socrates in Plato, The Republic, (trans) A. Bloom,
Harper Collin publisher, UK, 1968
19 T. Aquinas, On Law, Morality, and Politics, (trans)
RJ Regan, WP Baumgarth, Hackett Publisher Co,
2003
20 Grotius, The Rights of War and Peace, (trans)
J.Barbeyrac, Liberty Fund, Indianapolis, 2005
21 B. Koo & BD Wright, 'The role of biodiversity
products as incentives for conserving biological
diversity: some instructive examples', (1999) 240,
The Science of the Total Environment, 21-30
